Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma.
Ontology highlight
ABSTRACT: Retinoblastoma is the most common pediatric eye cancer. It is currently treated with a limited number of drugs, adapted from other pediatric cancer treatments. Drug toxicity and relapse of the disease warrant new therapeutic strategies for these young patients. In this study, we developed a robust tumoroid-based platform to test chemotherapeutic agents in combination with focal therapy (thermotherapy) - a treatment option widely used in clinical practice - in accordance with clinically relevant trial protocols. The model consists of matrix-embedded tumoroids that retain retinoblastoma features and respond to repeated chemotherapeutic drug exposure similarly to advanced clinical cases. Moreover, the screening platform includes a diode laser (810 nm, 0.3 W) to selectively heat the tumoroids,
SUBMITTER: Sinenko IL
PROVIDER: S-EPMC10475790 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA